Nippon Express partners with Controlant for real-time pharma monitoring
Image by DC Studio
Nippon Express Holdings has signed a partnership agreement with Iceland-based Controlant.
Headquartered in Iceland, Controlant enables transportation intervention and automated product release in the highly regulated pharmaceutical industry. The company’s technology and services, including platforms compliant with FDA 21 CFR Part 11 and GxP – validated IoT loggers, have been adopted by global pharmaceutical companies and logistics service providers around the world.
The Nippon Express (NX) Group has positioned the healthcare industry as a priority industry in its NX Group Business Plan 2028 – Dynamic Growth 2.0 “Accelerating Sustainable Growth.” The Group has acquired Good Distribution Practices (GDP) and CEIV Pharma certification at 34 business locations in 24 countries/regions worldwide, and is working to build quality management systems and infrastructure.
Through this partnership agreement with Controlant, the NX Group will be able to provide transportation services with end-to-end monitoring of cargo status, especially for pharmaceutical and healthcare products requiring strict temperature control. Customers will also be able to optimise their supply chain processes by linking the NX Group’s e-NX Visibility tracking system with Controlant’s real-time data logger.
The NX Group aims to contribute to the health of people around the world by supporting its customers in the global pharmaceutical and healthcare industry from a logistics perspective through the establishment of a reliable and secure global pharmaceutical logistics platform.
Comment on this article below or via X: @IoTGN and visit our website IoT Global Network